Panagora Asset Management’s Ovid Therapeutics OVID Stock Holding History

Panagora Asset Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,633	Closed	-$6K	–	2185
2021 Q2	$6K	Sell	1,633 -138	-8%	-$545	﹤0.01%	2435
2021 Q1	$7K	Hold	1,771	–	–	﹤0.01%	2505
2020 Q4	$4K	Buy	+1,771	New	+$8.26K	﹤0.01%	2527
2018 Q1	–	Sell	-10,011	Closed	-$99K	–	2377
2017 Q4	$99K	Buy	+10,011	New	+$91.9K	﹤0.01%	1877

Other funds holding OVID

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Panagora Asset Management's OVID Position: Q3 2021 in Review

Panagora Asset Management sold out of Ovid Therapeutics (OVID) in Q3 2021, closing a stake of 1,633 shares — an estimated $6K sold.

Panagora Asset Management first reported a position in OVID in Q4 2017 and held it in 4 quarters. The position peaked at $99K in Q4 2017. 72 funds tracked by Wall St. Rank hold OVID as of Q3 2021.

Panagora Asset Management reported no remaining Ovid Therapeutics position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 1,633 Ovid Therapeutics shares in Q3 2021, an estimated $6K.
Panagora Asset Management first reported a position in Ovid Therapeutics in Q4 2017 and held it in 4 quarters.
Panagora Asset Management's Ovid Therapeutics position peaked at $99K in Q4 2017.
72 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.